|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1999-4-30
|
|
pubmed:abstractText |
Radioimmunoscintigraphy (RIS) is being used increasingly as a new investigation in the diagnosis of recurrent colorectal cancer. This study assessed the efficacy of 99mTc-radiolabelled PR1A3 scanning in a cohort of patients with possible recurrent colorectal cancer and the effects of scan interpretation on subsequent clinical management.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0007-1323
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
86
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
244-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10100796-Adult,
pubmed-meshheading:10100796-Aged,
pubmed-meshheading:10100796-Aged, 80 and over,
pubmed-meshheading:10100796-Antibodies, Monoclonal,
pubmed-meshheading:10100796-Carcinoembryonic Antigen,
pubmed-meshheading:10100796-Colorectal Neoplasms,
pubmed-meshheading:10100796-Female,
pubmed-meshheading:10100796-Humans,
pubmed-meshheading:10100796-Male,
pubmed-meshheading:10100796-Middle Aged,
pubmed-meshheading:10100796-Neoplasm Recurrence, Local,
pubmed-meshheading:10100796-Radioimmunodetection,
pubmed-meshheading:10100796-Sensitivity and Specificity,
pubmed-meshheading:10100796-Technetium,
pubmed-meshheading:10100796-Tomography, X-Ray Computed,
pubmed-meshheading:10100796-Treatment Outcome
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Effect of radioimmunoscintigraphy on the management of recurrent colorectal cancer.
|
|
pubmed:affiliation |
Department of Surgery, St Mark's Hospital, Harrow, UK.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
